BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15725472)

  • 21. Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin's disease: case report and literature review.
    Adiga GU; Abebe L; Wiernik PH
    Am J Hematol; 2003 Apr; 72(4):267-73. PubMed ID: 12666139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EBV negative Richter's syndrome from a coexistent clone after salvage treatment with alemtuzumab in a CLL patient.
    Janssens A; Berth M; De Paepe P; Verhasselt B; Van Roy N; Noens L; Philippé J; Offner F
    Am J Hematol; 2006 Sep; 81(9):706-12. PubMed ID: 16838338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Richter's transformation in chronic lymphocytic leukemia.
    Tsimberidou AM; Keating MJ
    Semin Oncol; 2006 Apr; 33(2):250-6. PubMed ID: 16616072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
    Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
    Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 Aberrations do not predict individual response to fludarabine in patients with B-cell chronic lymphocytic leukaemia in advanced stages Rai III/IV.
    Valgañón M; Giraldo P; Agirre X; Larráyoz MJ; Rubio-Martinez A; Rubio-Felix D; Calasanz MJ; Odero MD
    Br J Haematol; 2005 Apr; 129(1):53-9. PubMed ID: 15801955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a Richter syndrome with a monoclonal component from a true B-cell chronic lymphocytic leukemia (B-CLL) treated with fludarabine.
    Bernasconi P; Paulli M; Orlandi E; Perfetti V; Giardini I; Zibellini S; Vanelli L; Tenore AM; Algarotti A; Boni M; De Amici M; Brusamolino E; Lazzarino M
    Ann Hematol; 2007 Aug; 86(8):619-22. PubMed ID: 17356849
    [No Abstract]   [Full Text] [Related]  

  • 27. Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia.
    O'Brien S; Moore JO; Boyd TE; Larratt LM; Skotnicki A; Koziner B; Chanan-Khan AA; Seymour JF; Bociek RG; Pavletic S; Rai KR
    J Clin Oncol; 2007 Mar; 25(9):1114-20. PubMed ID: 17296974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health-related quality of life in younger patients with chronic lymphocytic leukemia treated with fludarabine plus cyclophosphamide or fludarabine alone for first-line therapy: a study by the German CLL Study Group.
    Eichhorst BF; Busch R; Obwandner T; Kuhn-Hallek I; Herschbach P; Hallek M;
    J Clin Oncol; 2007 May; 25(13):1722-31. PubMed ID: 17389338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fine-needle aspiration biopsy findings in patients with small lymphocytic lymphoma transformed to hodgkin lymphoma.
    Catrina Reading F; Schlette EJ; Stewart JM; Keating MJ; Katz RL; Caraway NP
    Am J Clin Pathol; 2007 Oct; 128(4):571-8. PubMed ID: 17875507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus reactivation is a potentially severe complication in chronic lymphocytic leukemia patients with poor prognostic biological markers and fludarabine refractory disease.
    Rath J; Geisler C; Christiansen CB; Hastrup N; Madsen HO; Andersen MK; Pedersen LB; Jurlander J
    Haematologica; 2008 Sep; 93(9):1424-6. PubMed ID: 18641020
    [No Abstract]   [Full Text] [Related]  

  • 31. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
    Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
    Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
    Abbott BL
    Clin Adv Hematol Oncol; 2004 Jul; 2(7):448-54. PubMed ID: 16163221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemophagocytic syndrome and Hodgkin's disease variant of Richter's syndrome after fludarabine for CLL.
    Chaker L; Segeren CM; Bot FJ; Maartense E
    Eur J Haematol; 2010 Jul; 85(1):91-2. PubMed ID: 20331737
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997.
    Flinn IW; Neuberg DS; Grever MR; Dewald GW; Bennett JM; Paietta EM; Hussein MA; Appelbaum FR; Larson RA; Moore DF; Tallman MS
    J Clin Oncol; 2007 Mar; 25(7):793-8. PubMed ID: 17283364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformation.
    Smit LA; van Maldegem F; Langerak AW; van der Schoot CE; de Wit MJ; Bea S; Campo E; Bende RJ; van Noesel CJ
    Haematologica; 2006 Jul; 91(7):903-11. PubMed ID: 16818277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Successful treatment with fludarabine of chronic lymphocytic leukemia associated with nephrotic syndrome].
    Takei K; Horikoshi A; Hosokawa Y; Sawada S; Horie T
    Rinsho Ketsueki; 2002 Nov; 43(11):993-7. PubMed ID: 12508485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: high response rate and disease eradication.
    Bosch F; Ferrer A; Villamor N; González M; Briones J; González-Barca E; Abella E; Gardella S; Escoda L; Pérez-Ceballos E; Asensi A; Sayas MJ; Font L; Altés A; Muntañola A; Bertazzoni P; Rozman M; Aymerich M; Giné E; Montserrat E
    Clin Cancer Res; 2008 Jan; 14(1):155-61. PubMed ID: 18172266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variant Richter's syndrome: a rare case of classical Hodgkin's lymphoma developing in a patient with chronic lymphocytic leukemia treated with fludarabine.
    Nemets A; Ben Dor D; Barry T; Ducach A; Blumental R; Ben Alon D; Lugassy G
    Leuk Lymphoma; 2003 Dec; 44(12):2151-4. PubMed ID: 14959863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I study of bryostatin 1 and fludarabine in patients with chronic lymphocytic leukemia and indolent (non-Hodgkin's) lymphoma.
    Roberts JD; Smith MR; Feldman EJ; Cragg L; Millenson MM; Roboz GJ; Honeycutt C; Thune R; Padavic-Shaller K; Carter WH; Ramakrishnan V; Murgo AJ; Grant S
    Clin Cancer Res; 2006 Oct; 12(19):5809-16. PubMed ID: 17020988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Richter syndrome with emphasis on large-cell non-Hodgkin lymphoma in previously unrecognized subclinical chronic lymphocytic leukemia.
    Jelić S; Jovanović V; Milanović N; Marinković M; Kovcin V; Milosević D; Vlajić M
    Neoplasma; 1997; 44(1):63-8. PubMed ID: 9201283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.